Skip to main content

Schneid Yair's Form 4 filing

Galera Therapeutics, Inc. (GRTX) · filed Feb 26, 2024

Accession no.
0001213900-24-016923
Filed
Feb 26, 2024, 4:06 PM ET
Trade date
Jan 29-Feb 8, 2024
Filing delay
28 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 7 non-derivative transactions. Open-market purchases total $166.4K. It was filed 28 days after the trade, past the 2-business-day deadline.

This filing was later replaced by the amendment 0001213900-24-038573 (May 1, 2024). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Schneid YairCIK 000200823310% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 29, 2024Common StockPPurchaseAcquired+150,000$0.18+$27,0007,260,801Direct
Jan 30, 2024Common StockPPurchaseAcquired+335,000$0.181+$60,6357,595,801Direct
Feb 5, 2024Common StockPPurchaseAcquired+97,402$0.184+$17,921.977,693,203Direct
Feb 6, 2024Common StockPPurchaseAcquired+25,000$0.201+$5,0257,718,203Direct
Feb 7, 2024Common StockPPurchaseAcquired+25,000$0.17+$4,2507,743,203Direct
Feb 7, 2024Common StockPPurchaseAcquired+150,000$0.1729+$25,9357,893,203Direct
Feb 8, 2024Common StockPPurchaseAcquired+150,000$0.171+$25,6508,043,203Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)